Publications

Refereed Publications (2000-present):

1. Allayee, H., Dominguez, K.M., Aouizerat, B.E., Krauss, R.M., Rotter, J.I., Lu, J., Cantor, R.M., de Bruin, T.W.A., & Lusis, A.J. (2000). Contribution of the hepatic lipase gene to the atherogenic lipoprotein phenotype in familial combined hyperlipidemia.  J. Lipid Res., 41, 245-252. PMID: 10681408
2. Superko, H.R. & Krauss, R.M. (2000). Garlic powder, effect on plasma lipids, postprandial lipemia, low-density lipoprotein particle size, high-density lipoprotein subclass distribution and lipoprotein (a). J. Amer. Coll. Cardiol., 35, 321-326. PMID: 10676676
3. Goldberg. A.P., Busby-Whitehead, M.J., Katzel, L.I., Krauss, R.M., Lumpkin, M., & Hagberg, J.M. (2000).  Cardiovascular fitness, body composition, and lipoprotein lipid metabolism in older men. J. Gerontol. A Biol. Med. Sci., 55A, M342-M349. PMID: 10843355
4. Dreon, D.M., Fernstrom, H.A., Williams, P.T., & Krauss, R.M. (2000). Reduced LDL particle size in children consuming a very-low-fat diet is related to parental LDL-subclass patterns. Amer. J. Clin. Nutr., 71, 1611-1616. PMID: 10837306
5. Kritchevsky, D., Tepper, S.A., Chen, S.C., Meijer, G.W., & Krauss, R.M. (2000). Cholesterol vehicle in experimental atherosclerosis. 23. Effects of specific synthetic triglycerides. Lipids, 35, 621-625. PMID: 10901423
6. Zhu, Y., Jong, M.C., Frazer, K.A., Gong, E., Krauss, R.M., Cheng, J.-F., Boffelli, D., & Rubin, E.M. (2000).  Genomic interval engineering of mice identifies a novel modulator of triglyceride production.  Proc. Natl. Acad. Sci. USA, 97, 1137-1142. PMCID: PMC15548, PMID: 10655497
7. Tribble, D.L., Krauss, R.M. Chu, B.M., Gong, E.L., Kullgren, B.R., Nagy, J.O., & La Belle, M. (2000).  Increased low-density lipoprotein degradation in aorta or irradiated mice is inhibited by preenrichment of low-density lipoprotein with alpha-tocopherol.  J. Lipid Res., 41, 1666-1672. PMID: 11013309
8. Medina, W.L., Nunes, V.S., Carrilho, A.J., Shimabukuru, A.F., Lottenberg, S.A., MacPherson, R., Krauss, R.M., & Quintão, E.C. (2000).  High-density lipoprotein cholesterol estrification and transfer rates to lighter density lipoproteins mediated by cholesteryl ester transfer protein in the fasting and postprandial periods are not altered in type 1 diabetes mellitus.  Eur. J. Intern. Med., 11, 264-270. PMID: 11025251
9. Tribble, D.L., Rizzo, M., Chait, A., Lewis, D.M., Blanche, P.J., & Krauss, R.M. (2001).  Enhanced oxidative susceptibility and reduced antioxidant content of metabolic precursors of small, dense, low-density lipoproteins. Am. J. Med., 110, 103-110. PMID: 1165551
10. Hollenberg, N.K., Anzalone, D.A., Falkner, B., Fisher, N.D., Hopkins, P.N., Hsueh, W., Hutchinson, H., Krauss, R.M., Price, D.A., Raskin, P., & Reaven, G.M. (2001). Familial factors in the antihypertensive response to lisinopril. Am. J. Hypertens., 14, 218-223. PMID: 11281232
11. Pennacchio, L.A., Olivier, M., Hubacek, J.A., Cohen, J.C., Cox, D.R., Fruchart, H.C., Krauss, R.M., & Rubin, E.M. (2001).  An apolipoprotein identified through comparative sequence analysis that influences triglyceride levels in humans and mice.  Science, 294, 169-173. PMID: 11588264
12. Edwards, K.L., Talmud, P.J., Newman, B., Krauss, R.M., & Austin, M.A. (2001).  Lipoprotein candidate genes for multivariate factors of the insulin resistance syndrome.  A sib-pair linkage analysis in woman twins.  Twin Res., 4, 41-7. PMID: 11665324
13. Forte, T.M., Subbanagounder, G., Berliner, J.A., Blanche, P.J., Clermont, A.O., Jia, Z., Oda, M.N., Krauss, R.M., & Bielicki, J.K. (2002).  Altered activities of anti-atherogenic enzymes LCAT, paraoxonase, and platelet-activating factor aetylhydrolase in atherosclerosis-susceptible mice.  J. Lipid Res., 43, 477-485. PMID: 11893784
14. Campos, E., Kotite, L., Blanche, P., Mitsugi, Y., Frost, P.H., Masharani, U., Krauss, R.M., & Havel, R.J. (2002). Properties of triglyceride-rich and cholesterol-rich lipoproteins in the remnant-like particle fraction of human blood plasma.  J. Lipid Res., 43, 365-374. PMID: 11893772
15. Berneis, K., La Belle, M., Blanche, P.J., & Krauss, R.M. (2002).  Analysis and quantitation of biotinylated apoB-containing lipoproteins with streptavidin-Cy3.  J. Lipid Res., 43, 1155-59. PMID: 12091501
16. Olin-Lewis, K., Krauss, R.M., La Belle, M., Blanche, P.J., Barrett, P.H.R., Wright, T.N., & Chait, A. (2002).  Apo C-III Content of Apo B-Containing Lipoproteins is Associated with Binding to the Vascular Proteoglycan, Biglycan. J. Lipid Res., 43, 1969-1977. PMID: 12401896
17. Pennachio, L.A., Olivier, M., Hubacek, J.A., Krauss, R.M., Rubin, E.M., & Cohen, J.C. (2002).  Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels.  Hum. Mol. Gen., 11, 3031-38. PMID: 12417524
18. Attie, A.D., Krauss, R.M., Gray-Keller, M.P., Brownlie, A., Miyazaki, M., Kastelein, J.J., Lusis, A.J., Stalehnhoef, A.F.H., Stoehr, J.P., Hayden, M.R., & Ntambi, J.M. (2002).  Relationship between stearoyl-CoA desaturase activity and plasma triglycerides in human and mouse hypertriglyceridemia.  J. Lipid Res.,  43, 1899-1907. PMID: 12401889
19. Krauss, R.M.  (2002). Is the size of low-density lipoprotein particles related to the risk of coronary heart disease?  J. Amer. Med. Assoc.,  287, 712-713. PMID: 1181524
20. Isaacsohn, J., Hunninghake, D., Schrott, H., Dujovne, C.A., Knopp, R., Weiss, S.R., Bays, H., Crouse, J.R., Davidson, M.H., Keilson, L.M., McKenney, J., Korenman, S.G., Dobs, A.S., Stein, E., Krauss, R.M., Maccubbin, D., Cho, M., Plotkin, D.J., & Mitchel, Y.B. (2003).  Effects of simvastatin, and HMG-CoA reductase inhibitor, in patients with hypertriglyceridemia.  Clin. Cardiol., 26, 18-24. PMID: 12539808
21. Williams, P.T., Superko, H.R., Haskell, W.L., Alderman, E.L., Blanche, P.J., Holl, L.G., & Krauss, R.M. (2003).  Smallest LDL particles are most strongly related to Coronary Disease Progression in Men. Arterioscler. Thromb. Vasc. Biol.,  23, 314-21. PMID: 12588777
22. Goodarzi, M.O., Guo, X., Taylor, K.D., Quinones, M.J., Samayoa, C., Yang, H., Saad, M.F., Palotie, A., Krauss, R.M., Hsueh, W.A., & Rotter, J.I. (2003). Determination and use of haplotypes: ethnic comparison and association of the lipoprotein lipase gene and coronary artery disease in Mexican-Americans. Genet Med., 5, 322-327. PMID: 12865761
23. Rizzo, M., Taylor, J.M., Barbagallo, C.M., Berneis, K., Blanche, P.J., & Krauss, R.M. (2004).  Effects on lipoprotein subclasses of combined expression of human hepatic lipase and human apoB in transgenic rabbits. Arterioscler. Thromb. Vasc. Biol., 24, 141-146. PMID: 14615390
24. Farahani, P., Chiu, S., Bowlus, C.L., Boffelli, D., Lee, E., Fisler, J.S., Krauss, R.M., & Warden, C.H. (2004).  Obesity in BSB Mice is correlated with expression of genes for iron homeostasis and leptin.  Obesity Research, 12, 191-204. PMID: 14981211
25. Berneis, K., Shames, D.M., Blanche, P.J., La Belle, M., Rizzo, M., & Krauss, R.M. (2004).  Plasma clearance of human low-density lipoprotein in human apolipoprotein B transgenic mice is related to particle diameter.  Metabolism, 53, 483-87. PMID: 15045696
26. Georgieva, A.M., Van Greevenbroek, M.M.J., Krauss, R.M., Brouwers, M.C.G.J., Vermeulen, V.M.M.-J., Robertus-Tenissen, M.G., Van der Kallen, C.J.H., & de Bruin, T.W.A. (2004). Subclasses of low-density lipoprotein and very low-density lipoprotein in familial combined hyperlipidemia:  relationship to multiple lipoprotein phenotype. Arterioscler Thromb Vasc Biol., 24, 744-749. PMID: 14751815
27. Mar, R., Pajukanta, P., Allayee, H., Groenendijk, M., Dallinga-Thie, G., Krauss, R.M., Sinsheimer, J.S., Cantor, R.M., de Bruin, T.W.A., & Lusis, A.J. (2004).  Association of the APOLIPOPROTEIN A1/C3/A4/A5 gene cluster with triglyceride levels and LDL particle size in familial combined hyperlipidemia.  Circ. Res., 94, 993-999. PMID: 15001527
28. Licinio, J., S. Caglayan, M. Ozata, B.O. Yildiz, P.B. de Miranda, F. O’Kirwan, R. Whitby, Liang, L., Cohen, P., Bhasin, S., Krauss, R.M., Veldhuis, J.D., Wagner, A.J., DePaoli, A.M., McCann, S.M., & Wong, M.L. (2004).  Phenotypic effects of leptin replacement on morbid obesity, diabetes mellitus, hypogonadism, and behavior in leptin-deficient adults.  Proc. Natl. Acad. Sci. USA. 101, 4531-36. PMCID: PMC384781, PMID: 15070752
29. Wang, O.F., Liu, X., O’Connell, J., Peng, Z., Krauss, R.M., Rainwater, D.L., VandeBerg, J.L., Rubin, E.M., Cheng, J.F., & Pennacchio, L.A. (2004).  Haplotypes in the APOA1-C3-A4-A5 gene cluster affect plasma lipids in both humans and baboons.  Hum. Mol. Gen., 13, 1049-1056. PMID: 15044382
30. Badzioch, M.D., Igo, R.P., Gagnon, F, Brunzell, J.D., Krauss, R.M., Motulsky, A.G., Wijsman, E.M., & Jarvik, G.P. (2004). Low-density lipoprotein particle size loci in familial combined hyperlipidemia.  Arterioscler. Vasc. Biol., 24, 1942-1950. PMID: 15331429
31. Dubrac, S., Lear, S.R., Ananthanarayanan, M., Balasubramaniyan, N., Bollineni, J., Shefer, S., Hyogo, H., Cohen, D.E., Blanche, P.J., Krauss, R.M., Batta, A.K., Salen, G., Suchy, F.J., Maeda, N., & Erickson, S.K. (2005).  Role of CYP27A in cholesterol and bile acid metabolism.  J. Lipid Res., 46, 76-85. PMID: 15520450
32. Sattler, F.R., Schroeder, E.T., Dube, M.P., Jaque, S.V., Martinez, C., Blanche, P.J., Azen, S., & Krauss, R.M. (2002).  Metabolic effects of nandrolone decanoate and resistance training in men with HIV.  Am. J. Physiol. Endocrinol. Metab., 283, E1214-E1222. PMID: 12388173
33. Williams, P.T., Blanche, P.J., Rawlings, R.S., & Krauss, R.M. (2005).  Concordant lipoprotein and weight responses to dietary fat change in identical twins with divergent exercise levels.  Am. J. Clin. Nutr., 82, 181-187. PMID: 16002817
34. Williams, P.T., Blanche, P.J., & Krauss, R.M. (2005).  Behavioral versus genetic correlates of lipoproteins and adiposity in identical twins discordant for exercise.  Circulation, 112, 350-356. PMID: 16009789
35. McLaughlin, T., Reaven, G., Abbasi, F., Lamendola, C., Saad, M., Waters, D., Simon, J., & Krauss, R.M. (2005).  Is there a simple way to identify insulin-resistant individuals at increased risk of cardiovascular disease?  Am. J. Cardiol., 96, 399-404. PMID: 16054467
36. Krauss, R.M. (2005). Dietary and genetic probes of atherogenic dyslipidemia. Arterioscler. Thromb. Vasc. Biol., 25, 2265-2272. PMID: 161666563
37. Krauss, R.M., Blanche, P.J., Rawlings, R.S., Fernstrom H.S., & Williams, P.T. (2006).  Separate effects of reduced carbohydrate and weight loss on atherogenic dyslipidemia. Am. J. Clin. Nutr., 83, 1025-1031. PMID: 16685042
38. Simon, J.A., Lin, F., Hulley, S.B., Blanche, P.J., Waters, D., Shiboski, S., Rotter, J.I., Nickerson, D.A., Yang, H., Saad, M., & Krauss, R.M. (2006).  Phenotypic predictors of response to simvastatin therapy among African Americans and Caucasians: the Cholesterol and Pharmacogenetics (CAP) Study. Am. J. Cardiology, 97, 843-850. PMID: 16516587
39. Barter, P.J., Ballantyne, C.M., Carmena, R., Castro Cabezas, M., Chapman, M.J., Couture, P., De Graff, J, Durrington, P.N., Faergeman, O., Frohlich, J., Furberg, C.D., Gagne, C., Haffner, S.M., Humphries, S.E., Jungner, I., Krauss, R.M., Kwiterovich, P., Marconiva, S., Packard, C.J., Pearson, T.A., Srinath Reddy, K., Rosenson, R., Sarrafzadegan, N., Sniderman, A.D., Stalenhoef, A.F., Stein, E., Talmud, P.J., Tonkin, A.M., Walldius, G., & Williams, K.M.S. (2006).  Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel.  J. Internal Medicine, 259, 247-258. PMID: 16476102
40. Jacobs, K.A., Krauss, R.M., Fattor, J.A., Horning, M.A., Friedlander, A.L., Bauer, T.A., Hagobian, T.A., Wolfel, E.E., & Brooks, G.A. (2006).  Endurance training has little effect on active muscle free fatty acid, lipoprotein cholesterol or triglyceride net balances.   Am. J. Physiol. Endocrin. Metab., 291, E656-65. PMID: 16684856
41. Shin, M.J., Blanche, P.J., Rawlings, R.S., Fernstrom, H.S., & Krauss, R.M. (2007).  Increased plasma concentrations of lipoprotein (a) during a low fat, high-carbohydrate diet are associated with increased plasma concentration of apolipoprotein C-III bound to apolipoprotein B-containing lipoproteins. Amer. J. Clin. Nutr., 85, 1527-32.  PMID: 17556688
42. Su. X., Lee, L., Li, X., Lu, J., Hu, Y., Zhan, S., Cao, W., Mei, L., Tang, Y.M., Wang, D., Krauss, R.M., Rotter J.I., & Yang, H. (2007).  Association between angiotensin II receptor genes and blood pressure response to ACE inhibitor. Circulation, 115, 725-32. PMID: 17261659
43. Mangravite, L.M., Dawson, K., Davis, R.R., Gregg, J.P., & Krauss, R.M. (2007).  Fatty acid desaturase regulation in adipose tissue by dietary composition is independent of weight loss and correlated with plasma triacylglycerol response. Amer. J. Clin. Nutr., 26, 759-67. PMCID: 17823443
44. Moran, A, Simon, J.A., Shiboski, S., Pickering, T.G., Waters, D., Rotter, J.I., Lyon, C., Nickerson, D.A., Yang, H., Saad, M., Hsueh, W., & Krauss, R.M. (2007). Differential effects on ramipril on ambulatory blood pressure in African Americans and Caucasians.  Amer. J. Hypertension, 20, 884-891. PMID: 17679038
45. Ntukidem, N.I., Nguyen, A.T., Stearns, V., Rehman, M., Schott, A., Skaar, T., Jin, Y., Blanche, P.J., Li, L., Lemler, S., Hayden, J., Krauss, R.M., Desta, Z., Flockhart, D.A., & Hayes, D.F. for The Consortium on Breast Cancer Pharmacogenomics (COBRA). (2007). Estrogen receptor genotypes, menopausal status, and the lipid effects of tamoxifen. Clin. Pharm. & Therap., 83, 702-710. PMCID: PMC2782693, PMID: 17713466
46. Shin, M.J., Kanaya, A.M., & Krauss, R.M. (2008). Polymorphisms in the peroxisome proliferator activated receptor a gene are associated with levels of apolipoprotein CIII and triglyceride in African-Americans but not Caucasians. Atherosclerosis, 198, 313-319. PMCID: PMC2678963, PMID: 18061194
47. Van, J., Pan, J., Charles, M.A., Krauss, R.M., Wong N.D., & Wu, X. (2007). Atherogenic lipid phenotype in a general group of subjects. Arch. Pathol. Lab. Med., 131, 1679-1685. PMID: 17979486
48. Chen, W., Wang, S., Ma, Y., Zhou, Y., Liu, H., Strnad, P., Kraemer, F.B., Krauss, R.M., & Liu, J. (2008). Analysis of polymorphisms in the 3’ untranslated region of the LDL receptor gene and their effect on plasma cholesterol levels and drug response. Intl. J. Molec. Med., 21, 345-353.  PMID: 18288382.
49. Krauss, R.M., Mangravite, L.M., Smith, J.D., Medina, M.W., Wang, D., Guo, X., Rieder, M.J., Simon, J.A., Hulley, S.B., Waters, D., Saad, M., Williams, P.T., Taylor, K.D., Yang, H., Nickerson, D.A., & Rotter, J.I. (2008). Variation in the hydroxymethyl glutaryl coenzyme a reductase gene is associated with racial differences in low-density lipoprotein cholesterol response to simvastatin treatment. Circulation, 117, 1537-44.  PMID:  18332269
50. Reiner, A.P., Barber, M.J., Guan, Y., Ridker, P.M., Lange, L.A., Chasman, D.I., Walston, J.D., Cooper, G.M., Jenny, N.S., Rieder, M.J., Durda, P., Smith, J.D., Novembre, J., Tracy, R.P., Rotter, J.I., Stephens, M., Nickerson D.A., & Krauss, R.M. (2008). Polymorphisms of the HNF1A gene encoding hepatocyte nuclear factor-1a are associated with C-reactive protein. Amer. J. Hum. Genetics, 82, 1-9. PMCID: PMC2427318, PMID: 18439552
51. Swarbrick, M.M., Stanhope, K.L., Elliott, S.S., Graham, J.L., Krauss, R.M., Christiansen, M.P., Griffen, S.C., Keim, N.L., & Havel, P.J. (2008). Consumption of fructose-sweetened beverages for 10 weeks increases postprandial triacylglycerol and apolipoprotein-B concentrations in overweight and obese women. Br. J. Nutr., 100, 947-952. PMID: 18384705
52. Caulfield, M.P., Li, S., Lee, K., Blanche, P.J., Salameh, W.A., Benner, W.H., Reitz, R.E., & Krauss, R.M. (2008). Direct determination of lipoprotein particle size and concentration by ion mobility analysis. Clin. Chem., 54, 1307-1316. PMID: 18515257
53. Medina, M.W., Gao, F., Ruan, W., Rotter, J.I., & Krauss, R.M (2008). Alternative splicing of HMGCR is associated with plasma LDL cholesterol response to simvastatin. Circulation, 118, 355-362. PMCID: PMC2720070, PMID:  18559695
54. Paschou, P., Drineas, P., Lewis, J., Nievergelt, C.M., Nickerson, D.A., Smith, J.D., Ridker, P.M., Chasman, D.I., Krauss, R.M., & Ziv, E. (2008). Tracing sub-structure in the European American population with PCA-informative markers. PLoS Genetics, 4, e1000114. PMCID: 18797516
55. Wilke, R.A., Berg, R.L., Linneman, J.G., Zhao, C.F., McCarty, C.M., & Krauss, R.M. (2008). Characterization of LDL-cholesterol lowering efficacy for atorvastatin in a population-based DNA Biorepository. Basic Clin. Pharm. Tox., 103, 354-359. PMCID: PMC2537989, PMID: 18834356
56. Bergmark, C., Dewan, A. Orsoni, A., Merki, E., Miller, E.R., Shin, M.J., Binder, C.J., Hörkkö, S., Krauss, R.M., Chapman, M.J., Witztum, J.L., & Tsimikas, S. (2008). A novel function of lipoprotein (a) as a preferential carrier of oxidized phospholipids in human plasma. J. Lip. Res., 49, 2230-2239. PMID: 18594118
57. Ruby, M.A., Nomura, D.K., Hudak, C.S., Mangravite, L.M., Chiu, S., Casida, J.E., & Krauss, R.M. (2008). Overactive endocannabinoid signaling impairs apolipoprotein E-mediated clearance of triglyceride-rich lipoproteins. Proc. Natl. Acad. Sci. USA, 105, 14561-14566. PMCID: PMC2567196, PMID: 18794527
58. Chasman, D.I., Paré, G., Zee, R.Y.L., Parker, A.N., Cook, N.R., Buring, J.E., Kwiatkowski, D.J., Rose, L.M., Smith, J.D., Williams, P.T., Rieder, M.J., Rotter, J.I., Nickerson, D.A., Krauss, R.M., Miletich, J.P., & Ridker, P.M. (2008). Genetic loci associated with plasma concentration of low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, triglycerides, apolipoprotein A1, and apolipoprotein B among 6382 white women in genome-wide analysis with replication. Circ. Cardiovasc. Genet., 1, 21 - 30. PMCID: PMC2630707, PMID: 9802338
59. Itsara, A., Cooper, G.M., Baker, C., Girirajan, S., Li, J., Absher, D., Krauss, R.M., Myers, R.M., Ridker, P.M., Chasman, D.I., Mefford, H., Ying, P., Nickerson, D.A., & Eichler, E.E. (2009). Population analysis of large copy number variants and hotspots of human genetic disease.  Am. J. Hum. Genetics, 84,148-61. PMCID: PMC2668011, PMID: 19166990
60. Mareedu, R.K., Modhia, F.M., Kanin, E.I., Linneman, J.G., Kitchner, T., McCarty, C., Krauss, R.M., & Wilke, R.A. (2009). Use of an electronic medical record to characterize cases of intermediate statin-induced muscle. Prev. Cardiology, 12, 1-7. PMID: 19476582; NIHMS395473
61. Siri-Tarino, P., Williams, P.T., Fernstrom, H.S., Rawlings, R.S., & Krauss, R.M. (2009). Reversal of small, dense LDL subclass phenotype by normalization of adiposity. Obesity, 17, 1768-75. NIHMS176454, PMID: 19498345
62. Stanhope, K.L., Schwarz, J.M., Keim, N.L., Griffen, S.C., Bremer, A.A., Graham, J.L., Hatcher, B., Cox, C.L., Dyachenko, A., Zhang, W., McGahan, J.P., Seibert, A., Krauss, R.M., Chiu, S., Schaefer, E.J., Ai, M., Otokaozawa, S., Nakajima, K., Nakano, T., Beysen, C., Hellerstein, M., Berglund, L., & Havel, P.J. (2009). Consuming fructose- not glucose-sweetened beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. J. Clin. Invest., 119, 1322-34. PMCID: PMC2673878, PMID: 19381015
63. Musunuru, K., Orho-Melander, M., Caulfield, M.P., Li, S., Salameh, W.A., Reitz, R.E., Berglund, G., Hedblad, B., Engstrom, G., Williams, P.T., Kathiresan, S., Melander, O., & Krauss, R.M.  (2009). Ion mobility analysis of liproprotein subfractions identified three independent axes of cardiovascular risk. Arterioscler Thromb Vasc Biol., 29, 1975-80. PMCID: PMC2772123, PMID: 19729614
64. Hamrefors, V., Orho-Melander, M., Krauss, R.M., Hedblad, B., Almgren, P., Berglund, G., & Melander, O. (2010). A gene score of nine LDL and HDL regulating genes is associated with fluvastatin induced cholesterol changes in women. J Lipid Res, 51, 625-34. PMID: 19773416, PMCID: PMC2817592
65. Siri-Tarino P., Sun, Q., Hu, F. & Krauss, R.M. (2010). A meta-analysis of prospective cohort studies evaluating the association of saturated fat with cardiovascular disease. Amer. J. Clin. Nutr., 91, 535-546. PMCID: PMC2824152, PMID: 20071648
66. Shin, M.-J. & Krauss, R.M. (2010). Apolipoprotein CIII bound to apoB-containing lipoproteins is associated with small, dense LDL independent of plasma triglyceride levels in healthy men. Atherosclerosis, 211, 337-341. (Non-NIH supported) PMID: 20303494
67. Barber, M.J., Mangravite, L.M., Hyde, C.L., Chasman, D.I., Smith, J.D., McCarty, C.A., Li, X., Wilke, R.A., Rieder, M.J., Williams, P.T., Ridker, P.M., Chatterjee, A., Rotter, J.I., Nickerson, D.A., Stephens, M., & Krauss, R.M. (2010). Genome-wide association of lipid-lowering response to statins in combined study populations. PLoS ONE, 5, e9763. PMID: 20339536, PMCID: PMC2842298
68. Henderson, G.C., Krauss, R.M., Fattor, J.A., Faghihnia, N., Luke-Zeitou, M., & Krauss, R.M. (2010). Plasma triglyceride concentrations are rapidly reduced following individual bouts of endurance exercise in women. Eur. J. Appl. Physiol., 109, 721-30. PMID: 20217117; PMCID: PMC2883923
69. Mangravite, L.M., Medina, M.W., Cui, J., Pressman, S., Smith, J.D., Rieder, M.J., Guo, X., Nickerson, D.A., Rotter, J.I., & Krauss, R.M. (2010). Combined influence of LDLR and HMGCR sequence variation on lipid-lowering response to simvastatin. Arterioscler. Thromb., 30, 1485-92. PMID: 20413733, NIHMS203361
70. Musunuru, K., Strong, A., Frank-Kamenetsky, M., Lee, N.E., Ahfeldt, T., Sachs, K.V., Li, X., Li, H., Kuperwasser, N., Ruda, V.M., Pirruccello, J.J., Muchmore, B., Prokunina-Olsson, L., Hall, J.L., Schadt, E.E., Morales, C.R., Lund-Katz, S., Phillips, M.C., Wong, J., Cantley W., Ejebe, K.G., Orho-Melander, M., Melander, O., Koteliansky, V., Fitzgerald, K., Krauss, R.M., Cowan, C.A., Kathiresan, S., & Rader, D.J. (2010). From noncoding variant to phenotype via SORT1 at the 1p13 cholesterol locus. Nature, 466, 714-719. PMID: 20696566 (Non-NIH supported)
71. Teslovich, T.M., Musunusru, K., Smith, A.V., Edmondson, A.C., Krauss, R.M. et al. (2010). Biological, clinical and population relevance of 95 loci for blood lipids. Nature, 466, 707-713. PMID: 20686565, PMCID: PMC3039276
72. Siri-Tarino P.W., Woods, A., Bray, G.A., & Krauss, R.M. (2010). Reversal of small, dense LDL subclass phenotype by weight loss is associated with impaired fat oxidation. Obesity, 19, 61-8. PMID: 20559299, PMCID: PMC3011022
73. Ruby, M.A., Goldenson, B., Orasanu, G., Johnston, T.P., Plutzky, J., & Krauss, R.M. (2010). VLDL hydrolysis by LpL activates PPAR-(alpha) through generation of unbound fatty acids. (2010). J. Lipid. Res., 51, 2275-81. PMID: 20421589; PMCID: PMC2903797
74. Kaddurah-Daouk, R., Baillie R.A., Zhu, H., Zeng, Z.B., Wiest, M.M., Nguyen, U.T., Watkins, S.M., & Krauss, R.M. (2010). Lipidomic analysis of variation in response to simvastatin in the cholesterol and pharmacogenetics study. Metabolomics, 6, 191-201. PMCID: PMC2862962.
75. Faghihnia, N., Tsimikas, S., Miller, E.R., Witztum, J.L., & Krauss, R.M. (2010). Changes in lipoprotein(a), oxidized phospholipids and LDL subclasses with a low-fat, high-carbohydrate diet. J. Lipid Res., 51, 3324-30. PMID: 20713651; PMCID: PMC2952573
76. Wilke, R.A., Xu, H., Denny, J.C., Roden, D.M., Krauss, R.M., McCarty, C.A., Davis, R.L., Skaar, T., Lamba, J., & Savova, G. (2011). The emerging role of electronic medical records in pharmacogenomcs. Clin. Pharmacol. Ther., 89, 379-86. PMID: 21248726; PMCID: PMC3204342
77. Rosenson, R.S., Brewer, H.B. Jr., Chapman, M.J., Fazio, S., Hussain, M.M., Kontush, A., Krauss, R.M., Otvos, J.D., Remaley, A.T., & Schaefer, E.J. (2011). HDL measures, particle heterogeneity, proposed nomenclature, and relation to atherosclerotic cardiovascular events. Clin. Chem., 57, 392-410. PMID: 21266551
78. Jones, M.R., Chua, A., Chen, Y.D., Li, X., Krauss, R.M., Rotter, J.I., Legro, R.S., Azziz, R. and Goodarzi, M.O. (2011). Harnessing expression data to identify novel candidate genes in polycystic ovary syndrome. PLos One, 6, e20120. PMID: 21611153, PMCID: PMC3096662
79. Medina, M.W., Gao, F., Naidoo, D., Rudel, L.L., Temel, R.E., McDaniel, A.L., Marshall, S.M. and Krauss, R.M. (2011). Coordinately regulated alternative splicing of genes involved in cholesterol biosynthesis and uptake. PLoS One, 6, e19420. PMID: 21559365, PMCID: PMC3084847
80. Sonestedt, E., Wirfält, E., Wallström, P., Gullberg, B., Drake, I., Hlebowicz, J., Fredrikson, G.N., Hedblad, B., Nilsson, J., Krauss, R.M. & Orho-Melander M. (2011). High disaccharide intake associated with atherogenic lipoprotein profile. British J. Nutr., 20, 1-8. PMID: 22011476; (Non-NIH supported)
81. Faghihnia, N., Siri-Tarino, P.W., Krauss, R.M., & Brooks, G.A. (2011). Energy substrate partitioning and efficiency in individuals with atherogenic lipoprotein phenotype. Obesity, 19, 1360-5. PMID: 21475144           
82. Bays, H.E., Schwartz, S., Littlejohn, T., Kerzner, B., Krauss, R.M., Karpf, D.B., Choi, Y.-J., Wang, X., Naim, S., & Roberts B.K. (2011). MBX-8025, A novel peroxisome proliferator receptor-d agonist: lipid and other metabolic effects in dyslipidemic overweight patients treated with and without atorvastatin. J. Clin. Endocrinol. Metab., 96, 2889-97. PMID: 21752880; PMCID: PMC3124561   
83. Kaddurah-Daouk, R., Baillie, R.A., Zhu, H., Zeng, Z.-B., Wiest, M.W., Nguyen, U.T., Wojnoonski, K., Watkins, S.M., Trupp, M. & Krauss, R.M. (2011). Enteric microbiome metabolites correlate with response to simvastatin treatment. PLoS ONE, 6, e25482. PMID: 22022402; (Non-NIH supported)
84. Mangravite, L.M., Chiu, S., Wojnoonski, K., Rawlings, R.S., Bergeron, N. & Krauss, R.M. (2011). Changes in atherogenic dyslipidemia induced by carbohydrate restriction in men are dependent on dietary protein source. J. Nutr., 141, 2180-2185. PMID: 22031660; PMCID: PMC3223875 [Available on 2012/12/1]
85. Ruby, M.A., Nomura, D.K., Hudak, C.S., Barber, A,. Casida, J.E., & Krauss R.M. (2011). Acute overactive endocannabinoid signaling induces glucose intolerance, hepatic steatosis, and novel cannabinoid receptor 1 responsive genes. PLoS One, 6, e26415. PMCID: PMC3208546
86. Choi, Y.-J., Roberts, B.K., Wang, X., Geaney, J.C., Naim, S., Wojnoonski, K., Karpf, D.B. & Krauss, R.M. (2011). Effects of the PPAR-δ agonist MBX-8025 on atherogenic dyslipidemia. Atherosclerosis, 220, 470-476. PMID: 22169113; (Non-NIH supported)
87. Goodarzi, M.O., Jones, M.R., Li, X., Chua, A.K., Garcia, O.A., Chen Y.-D., Krauss, R.M., Rotter, J.I., Ankener, W., Legro, R.S., Azziz, R., Strauss III, J.F., Dunaif, A. & Urbanek, M. (2011). Replication of association of DENND1A and THADA variants with polycystic ovary syndrome in European cohorts. J. Med. Genet., 4, 90-95. PMID: 22180642; [PubMed - in process]
88. Hyysalo, J., Stojkovic, I., Kotronen, A., Hakkarainen, A., Sevastianova, K., Makkonen, J., Lundbom, N., Rissanen, A., Krauss, R. M., Melander, O., Orho-Melander, M. & Yki-Jarvinen, H. (2012) Genetic variation in PNPLA3 but not APOC3 influences liver fat in non-alcoholic fatty liver disease. J. Gastroenterol. Hepatol., 27, 951-956. PMID: 22141340
89. Jones, M. R., Chua, A. K., Mengesha, E. A., Taylor, K. D., Chen, Y. D., Li, X., Krauss, R. M., Rotter, J. I., Legro, R. S., Azziz, R. & Goodarzi, M. O. (2012).Metabolic and cardiovascular genes in polycystic ovary syndrome: a candidate-wide association study (CWAS). Steroids. 77, 317-322. PMID: 22178785
90. Krauss, R. M., Wojnooski, K., Orr, J., Geaney, J. C., Pinto, C. A., Liu, Y., Wagner, J. A., Luk, J. M., Johnson-Levonas, A. O., Anderson, M. S. & Dansky, H. M. (2012). Changes in lipoprotein subfraction concentration and composition in healthy individuals treated with the CETP inhibitor anacetrapib. J. Lipid Res., 53, 540-547. PMID: 22180633; 22180633; PMCID: PMC3276477
91. Page, S. T., Krauss, R. M., Gross, C., Ishida, B., Heinecke, J. W., Tang, C., Amory, J. K., Schaefer, P. M., Cox, C. J., Kane, J., Purnell, J. Q., Weinstein, R. L & Vaisar, T. (2012). Impact of mifepristone, a glucocorticoid/progesterone antagonist, on HDL cholesterol, HDL particle concentration, and HDL function. J. Clin. Endocrinol. Metab., 97, 1598-1605. PMID: 22399518; PMCID: PMC3339893
92. Zhang, L., Yan, F., Zhang, S., Lei, D., Charles, M. A., Cavigiolio, G., Oda, M., Krauss, R. M., Weisgraber, K. H., Rye, K. A., Pownall, H. J., Qiu, X. & Ren, G. (2012). Structural basis of transfer between lipoproteins by cholesteryl ester transfer protein. Nature Chem. Biol., 8, 342-349. PMID: 22344176
93. Mietus-Snyder, M.L., Shigenaga, M.K., Suh, J.H., Shenvi, S.V., Lal, A., McHugh, T., Olson, D., Lilienstein, J., Krauss, R.M., Gildengoren, G., McCann, J.C. & Ames, B.N. (2012). A nutrient-dense, high-fiber, fruit-based supplement bar increases HDL cholesterol, particularly large HDL, lowers homocysteine, and raises glutathione in a 2-wk trial. The FASEB Journal, 26, 3515-27. PMID: 22549511; PMCID: PMC3405270
94. Wilke, R.A., Ramsey, L.B., Johnson, S.G., Maxwell, W.D., McLeod, H.L., Voora, D., Krauss, R.M., Roden, D.M., Feng, Q., Cooper-DeHoff, R.M., Gong, L., Klein, T.E., Wadelius, M. & Niemi, M. (2012). The Clinical Pharmacogenomics Implementation Consortium CPIC guideline for SLCO1B1 and simvastatin-induced myopathy. Clin. Pharmacol. Therap., 92, 112-117. PMID: 22617227; PMCID: PMC3384438
95. Silver, H.J., Niswender, K.D., Keil, C.D., Jiang, L., Feng, Q., Chiu, S., Krauss, R.M. & Wilke, R.A. (2012). CNR1 Genotype influences HDL-Cholesterol reponse to change in dietary fat intake. PLoS ONE, 7, 1-8. PMID: 22567136; PMCID: PMC3342253
96. Dastani, Z., Hivert, M.F., Krauss, R.M. et al. (2012). Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals. PLoS Genet., 8, e1002607. PMID: 22479202; PMCID: PMC3315470
97. Musunuru, K., Romaine, S.P., Lettre, G., Wilson, J.G., Volcik, K.A., Tsai, M.Y., Taylor H.A. Jr., Schreiner, P.J., Rotter, J.I., Rich, S.S., Redline, S., Psaty, B.M., Papanicolaou, G.J., Ordovas, J.M., Liu, K., Krauss, R.M., Glazer, N.L., Gabriel, S.B., Fornage, M., Cupples, L.A., Buxbaum, S.G., Boerwinkle, E., Ballantyne, C.M., Kathiresan, S. & Rader, D.J. (2012). Multi-Ethnic Analysis of Lipid-Associated Loci: The NHLBI CARe Project. PLoS One, 7, e36473. PMID: 2269316; PMCID: PMC3357427
98. Trupp, M., Zhu, H., Wikoff, W.R., Baillie, R.A., Zeng, Z.B., Karp, P.D., Fiehn, O., Krauss, R.M. & Kaddurah-Daouk, R. (2012). Metabolomics reveals amino acids contribute to variation in response to simvastatin treatment. PLoS One, 7, e38386. PMID: 22808006; PMCID: PMC3392268
99. Jones, M.R., Chazenbalk, G., Xu, N., Chua, A.K., Eigler, T., Mengesha, E., Chen, Y.H., Lee, J.M., Pall, M., Li, X., Chen, Y.D., Taylor, K.D., Mathur, R., Krauss, R.M., Rotter, J.I., Legro, R.S., Azziz, R. & Goodarzi, M.O. (2012). Steroidogenic regulatory factor FOS is underexpressed in polycystic ovary syndrome (PCOS) adipose tissue and genetically associated with PCOS susceptibility. J. Clin. Endocrinol. Metab., 97, E1750-7. PMID: 22723319; PMCID: PMC3431575
100. Faghihnia, N., Mangravite, L.M., Chiu, S., Bergeron, N. & Krauss, R.M. (2012). Effects of dietary saturated fat on LDL subclasses and apolipoprotein CIII in men. Eur. J. Clin. Nutr., 66, 1229-33. PMID: 22948944. PMCID: PMC3491165
101. Brown, C.C., Havener,T.M., Medina, M.W., Auman, J.T., Mangravite, L.M., Krauss, R.M., McLeod, H.L. & Motsinger-Reif, A.A. (2012). A genome-wide association analysis of temozolomide response using lymphoblastoid cell lines shows a clinically relevant association with MGMT. Pharmacogenet. Genomics. 22:796-802. PMID: 23047291. PMCID: PMC3691078
102. Medina, M.W., Theusch, E., Naidoo, D., Bauzon, F., Stevens, K., Mangravite, L.M., Kuang, Y.L. & Krauss, R.M. (2012). RHOA is a modulator of the cholesterol-lowering effects of statin. PLOS Genetics, 8, e1003058. PMID: 23166513, PMCID: PMC3499361
103. Gao, F., Ihn, H.E., Medina M.W. & Krauss, R.M. (2013). A common polymorphism in the LDL receptor gene has multiple effects on LDL receptor function. Hum. Mol. Genet., 22, 1424-31. PMID: 23297366, PMCID: PMC3596853
104. Medina, M.W. & Krauss, R.M. (2013). Alternative splicing in the regulation of cholesterol homeostasis. Curr. Opin. Lipidol. 22, 1424-31. PMID: 23314925; PMCID: PMC3596853
105. Holzinger, E.R., Dudek, S.M., Frase, A.T., Krauss, R.M., Medina, M.W. & Ritchie, M.D. (2013). ATHENA: a tool for meta-dimensional analysis applied to genotypes and gene expression data to predict HDL cholesterol levels. Pac Symp Biocomput., 2013, 385-96. PMID: 23424143; PMCID: PMC3587764
106. Williams, Paul T., Zhao, X.-Q., Marcovina, S.M., Brown, B.G. & Krauss, R.M. (2013). Levels of cholesterol in small LDL particles predict atherosclerosis progression and incident CHD in the HDL-atherosclerosis treatment study (HATS). PLoS One, 8, e56782. PMID: 23460815; PMCID: PMC3584097
107. Koeth, R.A., Wang, Z., Levison, B.S., Buffa, J.A., Org, E., Sheehy, B.T., Britt, E.B., Fu, X., Li, L., Smith, J.D., Didonato, J.A., Chen, J., Li, H., Wu, G.D., Lewis, J.D., Warrier, M., Brown, J.M., Krauss, R.M., Tang, W.H., Bushman, F.D., Lusis, A.J. & Hazen, S.L. (2013). Intestinal microbiota metabolism of I-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat. Med., 19, 576-85. PMID: 23563705; PMCID: PMC3650111
108. Goodarzi, M.O., Li, X., Krauss, R.M., Rotter, J.I. & Chen, Y-D.I. (2013). Relationship of sex to diabetes risk in statin trials. Diabetes Care, 36, e100-101. PMID: 23801803, PMCID: PMC3687308
109. Toth, P.P., Barter, P.J., Rosenson, R.S., Boden W.E., Chapman, M.J., Cuchel, M., D’Agostino, R.B. Sr., Davidson, M.H., Davidson, W.S., Heinecke, J.W., Karas, R.H., Kontush, A., Krauss, R.M., Miller, M. & Rader, D.J. (2013). High-density lipoproteins: A consensus statement from the National Lipid Association. J. Clin. Lipidol., 7, 484-525. PMID: 24079290. [PubMed – in process]
110. Mangravite, L.M., Engelhardt, B.E., Medina, M.W., Smith, J.D., Brown, C.D., Chasman, D.I., Mecham, B.H., Howie, B., ,Shim, H., Naidoo, D., Feng, Q., Rieder, M.J., Chen, Y.D., Rotter, J.I., Ridker, P.M., Hopewell, J.C., Parish, S., Armitage, J., Collins, R., Wilke, R.A., Nickerson, D.A. & Stephens, R.M. (2013). A statin-dependent QTL for GATM expression is associated with statin-induced myhopathy. Nature, 502: 377-80. PMID: 23995691. NIHMSID# 510334.
111. Wei, W.Q., Feng, Q., Jiang, L., Waitara, M.S., Iwuchukwu, O.F., Roden, D.M., Jiang, M., Xu, H., Krauss, R.M., Rotter, J.I., Nickerson, D.A., Davis, R.L., Berg, R.L., Peissig, P.L., McCarty, C.A., WIlke, R.A. & Denny, J.C. (2013). Characterization of Statin Dose-response withing Electronic Medical Records. Clin. Pharmacol. Ther. [Epub ahead of print]. PMID: 24096969
112. Global Lipids Genetics Consortium. Krauss, R.M. et al. (2013). Discovery and refinement of loci associated with lipid levels. Nat. Genet., 45, 1274-83. PMID: 24097068
113. Do, R., Krauss, R.M. et al. (2013). Common variants associated with plasma triglycerides and risk for coronary artery disease. Nat. Genet., 45, 1345-52. PMID: 24097064
114. Bolotin, E., Armendariz, A., Kim, K., Heo, S.J., Boffelli, D., Tantisira, K., Rotter, J.I., Krauss, R.M. & Medina, M.W. (2013). Statin-induced changes in gene expression in EBV-transformed and native B-cells. Hum. Mol. Genet. [Epub ahead of print]. PMID: 24179175
     

Book Chapters, Proceedings, Reports, and Editorials

1. Krauss, R.M. (2000). [Editorial]. Genetic recipes for heart-healthy diets. Am. J. Clin. Nutr. 71:668-669.
2. Krauss, R.M.  (2000). New insights into lipoprotein metabolism: implications for early atherogenesis. In: CVD Prevention, Volume 2, Number 2, June.
3. Grundy, S.M., Bazzarre, T., Cleeman, J.B., D’Agostino, R.B., Hill, M., Houston-Miller, N., Kannel, W.B., Krauss, R.M., Krumholz, H.M., Lauer, R.M., Ockene, I.S., Pasternak, R.C., Pearson, T., Ridker, P.M. & Wood, D. (2000).  Prevention Conference V:  Beyond secondary prevention:  Identifying the high-risk patient for primary prevention.  Medical office assessment.  Circulation, 101:e3-e11.
4. Krauss, R.M., Eckel, R.H., Howard, B., Appel, L.J., Daniels, S.R., Deckelbaum, R.J., Erdman, Jr., J.W., Kris-Etherton, P., Goldberg, I.J., Kotchen, T.A., Mitch, W.E., Mullis, R., Robinson, K., Wylie-Rosett, J., St. Jeor, S., Suttie, J., Tribble, D. & Bazzarre, T.L. (2000). AHA Dietary Guidelines: Revision 2000: A statement for healthcare professionals from the Nutrition Committee of the American Heart Association. Circulation, 102: 2284-2299, and Stroke, 31:2751-2766.
5. Kris-Etherton, P., Daniels, S.R., Eckel, R.H., Engler, M., Howard, B.V., Krauss, R.M., Lichtenstein, A.H., Sacks, F., St. Jeor, S. & Stampfer, M. (2001).  AHA Conference Proceedings.  Summary of the scientific conference on dietary fatty acids and cardiovascular health Circulation 103:1034-1039.
6. Krauss, R.M. (2001). Dietary and genetic effects on low-density lipoprotein heterogeneity.  Annu. Rev. Nutr. 21:283-95.
7. Krauss, R.M. (2000). Genetic recipes for heart-healthy diets.  Am. J. Clin. Nutr. 71:668-669.
8. Tribble, D.L. & Krauss, R.M. (2000).  Atherosclerotic cardiovascular disease.  Present Knowledge in Nutrition. 543-551.
9. Krauss, R.M. (2001). Atherogenic lipoprotein phenotype and diet-gene interactions.  J. Nutr. 131:340S-343S. PMCID: 11160558
10. Krauss, R.M. (2001). Dietary and genetic effects on LDL heterogeneity.  Nutrition and Fitness, Diet, Genes, Physical Activity and Health. In: Simopoulos, A.P., Pavlou, K.N., eds.  World Review of Nutrition.  S. Karger, Basel, Switzerland, Vol. 89, Chapter 12:12-22.
11. Krauss, R.M. & Young, V.R. (2001).  Nutritional requirements of normal adults. Handbook of Nutrition and the Kidney, 4th Edition, Chapter 1.
12. Krauss, R.M.  (2002). Individualized hormone replacement therapy. New England Journal of Medicine. Vol. 346:1017-1018.
13. Krauss, R.M.  (2002). Diet and cardioprotection: sorting fact from fiction.  Menopause Management. Vol. 11:6-10.
14. Krauss, R.M. (2002). Is the size of low-density lipoprotein particles related to the risk of coronary heart disease?  J. AMER. MED. ASSOC., 287:712-713
15. Reaven, G.M., Cobin, R.H., Ford, E., Ganda, O.P., Handelsman, Y., Hellman, P.S., Kendall, D., Krauss, R.M., Neufeld, N.D., Petak, S.M., Rodbard, H.W., Seibel, J.A., Smith, D.A. & Wilson, P.W. (2003). American college of endocrinology position statement on the insulin resistance syndrome. Endocr. Pract. 9:237-252.
16. Krauss, R.M.  (2003). Insulin resistance syndrome and dyslipidemia.  Endocrine Practice. 9(Suppl 2):67. PMCID: 14698979
17. Krauss, R.M.  (2004). Hold the antioxidants and improve plasma lipids?  J. Clin. Invest. 113:1253-1255. PMCID: PMC398437
18. Krauss, R.M. & Siri, P.W. (2004).  Metabolic Abnormalities:  Triglyceride and LDL.  Endocrinology and Metabolism: Clinics of North America.  33:405-415.
19. Krauss, R.M. (2004). Lipids and lipoproteins in patients with type 2 diabetes.  Diabetes Care.  27:1496-1504.
20. Krauss, R.M. & Siri, P.W. (2004).  Dyslipidemia in type 2 diabetes.  The Medical Clinics of North America.  88:897-909.
21. Krauss, R.M. (2004). Atherogenic lipoproteins in the metabolic syndrome.  MetS Insights. 4:13-17.
22. Krauss, R.M. (2004). Nutrition and cardiovascular disease. In Zipes, D.P., Libby, P., Bonow, R.O. & Braunwald, E., eds. Braunwald’s Heart Disease 7th Edition. Elsevier Saunders.  Chapter 41:1047-1056.
23. Kris-Etherton, P.M., Hilpert, K.F. & Krauss, R.M. (2004). Nutrition in preventive cardiology a practical approach 2nd Edition.  Wong, N.D., Black, H.R. & Gardin, J.M., eds. The McGraw-Hill Companies.  Chapter 11, pp. 256-295.
24. Krauss, R.M.  (2005). Metabolic syndrome:  When and how to intervene.  OBG Management.  17:52-60.
25. Daignault, N.M., Evans, M.E., Krauss, R.M., et al. (2005). Nutritional requirements of healthy adults. In: Mitch, W.E. & Klahr, S., eds. Handbook of Nutrition and the Kidney. 5th ed. Philadelphia: Lippincott Williams & Wilkins.
26. Grundy S.M., Cleeman, J.I., Daniels, S.R., Donato, K.A., Eckel, R.H., Franklin, B.A., Gordon, F.J., Krauss, R.M., Savage, P.J., Smith, S.C., Spertus, J.A. & Costa, F. (2005).  Diagnosis and management of the metabolic syndrome.  An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement & Executive Summary.  Circulation. 112:e285-e290.
27. Siri, P.W. & Krauss, R.M. (2005). Influence of dietary carbohydrate and fat on LDL and HDL particle distributions. Curr. Atheroscler. Rep. 7:455-459.
28. Kaput, J. et al. (2005). The case for strategic international alliances to harness nutritional genomics for public and personal health. Br. J. Nutr. 94:623-632.
29. Fletcher, B. et al. (2005). Managing abnormal blood lipids: a collaborative approach. Circulation. 112:3184-3209.
30. Berneis, K. & Krauss, R.M. (2002).  Metabolic origins and clinical significance of LDL heterogeneity.  J. Lipid Res.  43:1363-79.
31. Mangravite, L.M., Thorn, C.F. & Krauss, R.M. (2006).  Clinical implications of pharmacogenomics of statin treatment.  Pharmacogenomics J. 6:360.
32. Krauss, R.M. & Siri, P.W. (2006).  Dietary and genetic effects on atherogenic dyslipidemia in Nutritional Genomics. In: Kaput, J. & Rodriguez R.L., eds.  Discovering the Path to Personalized Nutrition. John Wiley & Sons, Inc. Chapter 13:295-304.
33. Krauss, R.M., Blanche, P.J., Rawlings, R.S., Fernstrom, H.S. & Williams, P.T.  (2006). Reply to EC Westman et al. Am. J. Clin. Nutr. 84:1550. PMCID: 16685042
34. Roden, D.M., Altman, R.B., Benowitz, N.L., Flockhart, D.A., Giacomini, K.M., Johnson, J.A., Krauss, R.M., McLeod, H.L., Ratain, M.J., Relling, M.V., Ring, H.A.,, Shuldiner, A.R., Weinshilboum, R.M. & Weiss, S.T. (2006).  Pharmacogenomics: Challenges and Opportunities. Ann. Intern. Med. 145:749-757. PMCID: 17116919
35. Krauss, R.M. (2007). Lipids, Lipoproteins, and Effects of Hormonal Therapy. In: Lobo, R., ed. Treatment of the Postmenopausal Woman, Basic and Clinical Aspects., 3rd ed. Chapter 33:461-769.
36. Krauss R.M. (2007). Nutrition and Cardiovascular Disease. In: Libby, P., Bonow, R.O., Mann D.L. & Zipes D.P., eds. Braunwald’s Heart Disease. 8th ed. Chapter 44, November.
37. Siri-Tarino P.W., Feldman, E.B. and Krauss R.M. (2007). Effects of Diet on Cardiovascular Disease Risk. In: Berdanier, C.D., Dwyer, J. & Feldman, E.B., eds. The Handbook of Nutrition and Food. 2nd ed. Chapter 43:727-734.
38. Feldman, E.B., Siri, P.W. & Krauss, R.M. (2007). Hyperlipidemias: Major Gene and Diet Effects. In: Berdanier, C.D., Dwyer, J. & Feldman, E.B., eds. The Handbook of Nutrition and Food. 2nd ed. Chapter 42:715-726.
39. Krauss, R.M. & Swartzberg, J.E. (2007). The Wellness Report 2007: Controlling your Cholesterol.
40. Giacomini, K.M., Brett, C.M., Altman, R.B., Benowitz, N.L., Dolan, M.E., Flockhart, D.A., Johnson, J.A., Hayes, D.F., Klein, T., Krauss, R.M., Kroetz, D.L., McLeod, H.L., Nguyen, A.T., Ratain, M.J., Relling, M.V., Reus, V., Roden, D.M., Schaefer, C.A., Shuldiner, A.R., Skaar, T., Tantisira, K., Tyndale, R.F., Wang, L., Weinshilboum, R.M., Weiss, S.T. & Zineh, I. (2007). The Pharmacogenomics Research Network:  from SNP Discovery to Clinical Drug Response. Clin Pharm Ther. 81:328-345.
41. Giacomini, K.M., Krauss, R.M., Roden, D.M., Eichelbaum, M., Hayden, M.R. & Nakamura, Y. (2007). When good drugs go bad. Nature. 446:975-977.
42. Altman, R.B., Benowitz, N., Gurwitz, D., Lunshof, J., Relling, M., Lamba, J., Wieben, E., Mooney, S., Giacomini, K., Weiss, S., Johnson, J.A., McLeod, H., Flockhart, D., Weinshilboum, R., Shuldiner, A.R., Roden, D., Krauss, R.M. & Ratain, M. (2007). Genetic nondiscrimination legislation: a critical prerequisite for pharmacogenomics data sharing. Pharmacogenomics. 8:519.
43. Mangravite, L.M. & Krauss, R.M. (2007). Pharmacogenomics of statin response. Curr. Opin. Lipidol. 18:409-414. PMCID: 17620857
44. Krauss R.M. (2007). Clinical trials report: low-fat dietary pattern and risk of cardiovascular disease in the Women’s Health Initiative randomized controlled dietary modification trial. Curr. Atheroscler. Rep. 9:431-433.
45. Wilke, R.A., Lin, D.W., Roden, D.M., Watkins, P.B., Flockhart, D., Zineh, I., Giacomini, K.M. & Krauss, R.M. (2007). Identifying genetic risk factors for serious adverse drug reactions: current progress and challenges. Nature Rev. Drug Discov. 6:904-916. PMCID: PMC2763923
46. Krauss R.M. (2008). What can the genome tell us about LDL cholesterol? The Lancet. 371:450-452.
47. Sulkes, D., Brown, B.G., Krauss, R.M., Segrest, J.P., Sniderman, A.D. & Roberts, W.C. (2008). The Editor’s Roundtable: Expanded versus standard lipid panels in assessing and managing cardiovascular risk. American J. Cardiology. 101:828-42.
48. Layman, D.K., Clifton, P., Gannon, M.C., Krauss, R.M. & Nuttall, F.Q. (2008). Protein in optimal health: heart disease and type 2 diabetes. AJCN. 87:1571S-1575S.
49. Snyder, M. & Krauss, R.M. (2008).  Lipid metabolism in children and adolescents: Impact on vascular biology. J. Clin. Lipidology. 2:127-137.
50. Li, S., Lee, G., Blanche, P.J., Salameh, W.A. & Krauss, R.M. (2008).  Reply to Letter to the Editor on CLINCHEM/2007/100586. Clin. Chem. 54:1307-16.
51. Mangravite, L.M., Wilke, R.A., Zhang, J. & Krauss, R.M. (2008). Pharmacogenomics of Statin Response. Curr. Op. Mol. Ther. 10:555-561.
52. Krauss, R.M. (2008). Interview. Pharmacogenomics. 9:997-1000.
53. Swartzberg, J.E. & Krauss, R.M. (2008). The Wellness Report 2008. Controlling Your Cholesterol.
54. German, B., Gibson, R.R., Krauss, R.M., Nestel, P., Lamarche, B., van Staveren, W.A., Steijns, J.M., de Groot, L.C., Lock, A.L. & Destaillats, F. (2009). A reappraisal of the impact of dairy foods and milk fat on cardiovascular disease risk. Eur. J. Nutrition. 48:191-203. PMCID: PMC2695872
55. Armendariz, A.D. & Krauss, R.M. (2009). HNF1a: Inflammation, Genetics, and Atherosclerosis. Curr Opin Lipidol. 20:106-111.
56. Swartzberg, J.E. & Krauss, R.M. (2009). The Wellness Report 2009. Controlling Your Cholesterol.
57. Medina, M.W. & Krauss, R.M. (2009). The role of HMGCR alternative splicing in statin efficacy. Trends in Cardiovascular Medicine. 19:173-177. PMCID: PMC2805071
58. Siri-Tarino, P.W., Sun, Q., Hu, F. & Krauss, R.M. (2010). Saturated Fat, Carbohydrate and Cardiovascular Disease. Amer. J. Clin. Nutr., 91: 502-209. PMCID: PMC2824150
59. Krauss, R.M. (2010). Lipoprotein subfractions and cardiovascular disease risk. Curr Opin Lipidol., 4:305-11. PMCID: 20531184
60. Krauss, R.M. (2010). Phospholipid Transfer Protein and Atherosclerosis: Genetic Studies Take Aim at a Moving Target. 122:452-4. PMCID: 20644011
61. Siri-Tarino, P.W., Sun, Q., Hu, F.B. & Krauss R.M. (2010). Saturated Fatty Acids and Risk of Coronary Heart Disease: Modulation by Replacement Nutrients. Curr. Atheroscler. Rep. 12:384-90. PMID: 20711693; PMCID: PMC2943062
62. Astrup, A., Dyerberg, J., Elwood, P., Hermansen, K., Hu, F.B., Jakobsen, M.U., Kok, F.J., Krauss, R.M., Lecerf, J.M., LeGrand, P., Nestel, P., Risérus, U., Sanders, T., Sinclair, A., Stender, S., Tholstrup, T. and Willett, W.C. (2011). The role of reducing intakes of saturated fat in the prevention of cardiovascular disease: where does the evidence stand in 2010? Am. J. Clin. Nutr., 93:684-8. PMID: 21270379; PMCID: PMC3138219
63. Roden D.M., Johnson, J.A., Kimmel, S.E., Krauss, R.M., Medina, M.W., Shuldiner, A., & Wilke, R.A.. (2011) Cardiovascular pharmacogenomics. Circ Res. 109, 807-820.  PMID: 21921273; PMCID: PMC3201825
64. Krauss, R.M. & Williams, P.T. (2011). Alcohol and the heart: does raising high-density lipoprotein matter? Circulation, 124:2283-84. PMID: 22105194 Non NIH funded)
65. Swartzberg, J.E. & Krauss, R.M. (2011). The Wellness Reports 2011. Controlling Your Cholesterol.
66. Wilke, R.A., Antonik, M., Kanin, E.I., Feng, Q., & Krauss, R.M. (2012). Statin-Induced Muscle Toxicity. In: Altman, R.B., Flockhart, D. & Goldstein, D.B., eds. Principles of Pharmacogenetics and Pharmacogenomics. Chapter 12:125-135.
67. Chiu, S. & Krauss, R.M. (2012).  Obesity and lipoprotein metabolism.  In: Bray, G., James, P., Bouchard, C., eds. Handbook of Obesity, 3rd ed., vol. 1, Epidemiology, Etiology and Physiopathology, Marcel Dekker, Inc.
68. Krauss, R.M. & Kadurrah-Daouk, R. (2013). Pharmacometabolomics of statin response. Clin Pharmacol & Ther. [Epub ahead of print]

Revised: Friday, April 17, 2020 1:35 PM